Monoclonal myelopoiesis and subnormal erythropoietin concentration are independent risk factors for thromboembolic complications in essential thrombocythemia
Björn Andréasson(NU Hospital Group), Jack Kutti(Sahlgrenska University Hospital), David C. Linch(University of Oxford), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Göran Lindstedt(Sahlgrenska University Hospital)
Cited by 9
Related Papers
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
|Blood|2000|502
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis
|British Journal of Haematology|2005|339